Therapeutic Advances in Myelodysplastic Syndromes: From Investigation to Clinical Practice

Gain expert insights on current and emerging treatment options for managing low- intermediate- and high-risk myelodysplastic syndrome with a downloadable slideset from a satellite symposium an on-demand webcast and an expert commentary.

Share

Program Content

Activities

MDS Risk Stratification
Myelodysplastic Syndromes: Diagnosis and Risk Stratification
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

Lower-risk MDS Strategies
Strategies for Managing Very Low–Risk, Low-Risk, and Intermediate-Risk MDS
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

Higher-risk MDS Therapy
Latest Guidance on the Treatment of Higher-Risk MDS and Managing Relapsed/Refractory MDS
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

MDS Future Directions
Myelodysplastic Syndromes: Future Directions
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

No activities added yet

Activities

FAQs: Managing MDS
Managing Low- and High-Risk Myelodysplastic Syndromes: Experts Address FAQs
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 09, 2022

Expires: August 08, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Bristol Myers Squibb

Karyopharm Therapeutics Inc.